---
title: "ADC Therapeutics SA (ADCT.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/ADCT.US/norm.md"
symbol: "ADCT.US"
name: "ADC Therapeutics SA"
parent: "https://longbridge.com/zh-CN/quote/ADCT.US.md"
datetime: "2026-06-13T21:02:09.705Z"
locales:
  - [en](https://longbridge.com/en/quote/ADCT.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ADCT.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ADCT.US/norm.md)
---

# ADC Therapeutics SA (ADCT.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.2593 | -0.0426 | -0.3002 | -0.4980 | -0.3601 |
| ROE | 65.57% | 12.09% | 74.93% | 103.60% | 70.05% |
| 营业收入 | 20.85M | 23.06M | 16.43M | 18.84M | 23.03M |
| 净利润 | -32.97M | -6.41M | -40.97M | -56.65M | -38.60M |
| 营业利润 | -25.25M | -15.98M | -30.59M | -31.06M | -28.76M |
| 毛利率 | -12.67% | 23.68% | -70.48% | -64.16% | -34.54% |
| 净利率 | -158.11% | -27.80% | -249.38% | -300.68% | -167.59% |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 291.50M | 323.15M | 289.76M | 321.56M | 272.54M |
| 权益乘数 | -1.35 | -1.74 | -1.22 | -1.61 | -1.14 |
| 每股净资产 | -1.70 | -1.48 | -2.11 | -1.77 | -2.40 |
| 资产周转率 | 0.2807 | 0.2522 | 0.2355 | 0.2228 | 0.2612 |
| 现金及短投 | 231.01M | 261.34M | 234.74M | 264.56M | 194.70M |
| 存货与应收 | 4.78M | 4.18M | 18.04M | 17.76M | 17.45M |
| 长期投资 | 1.20M | 1.30M | 1.39M | 1.49M | 13.39M |
| 净债务 | 205.25M | 178.21M | 222.70M | 186.21M | 255.19M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -29.71M | -31.12M | -29.63M | -24.09M | -56.33M |
| 投资现金流 | -32000.00 | 659000.00 | 0.0000 | 0.0000 | -264000.00 |
| 融资现金流 | -583000.00 | 57.09M | -198000.00 | 93.78M | 271000.00 |
| 自由现金流 | -31.94M | 4.99M | -16.91M | -1.03M | -60.93M |
| 现金流充裕率 | -92843.75% | - | - | - | -21338.64% |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | -32000.00 | 0.0000 | 0.0000 | 0.0000 | -264000.00 |